Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Sterilization II: Chemical Methods01:30

Methods of Sterilization II: Chemical Methods

In healthcare, the chemical method of sterilization uses chemical sterilants to treat surgical instruments and medical supplies to help prevent the transmission of infectious pathogens to patients. Due to heat sensitivity, most medical supplies and equipment should not be exposed to high temperatures. These parts include rubber, plastic, glass, and other similar elements.
Using chemical sterilization rather than heat to clean out equipment is recommended. It eradicates and removes all bacteria,...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Hepatitis B screening disparities in the United States: An implementation-focused narrative review.

Public health·2026
Same author

Refining adjuvant therapy options in patients with stage II melanoma.

Immunotherapy·2026
Same author

National and state-level datasets of United States forensic DNA databases 2001-2025.

Scientific data·2026
Same author

Parotidectomy: 10-Year Experience in the Hands of Surgical Oncologists.

Journal of surgical oncology·2026
Same author

Age-stratified impact of microsatellite instability on lymph node positivity and survival in stage I-III colon cancer.

Journal of geriatric oncology·2026
Same journal

1776: Medical Care During the Revolutionary War.

Rhode Island medical journal (2013)·2026
Same journal

New HIV Diagnoses Among Hispanic/Latino Men Who Have Sex with Men, 2010-2024, Rhode Island.

Rhode Island medical journal (2013)·2026
Same journal

Improving Health Equity Training with an Integrated Simulation-Based Curriculum.

Rhode Island medical journal (2013)·2026
Same journal

Interpreter Use in an Academic Pediatric Hospital.

Rhode Island medical journal (2013)·2026
Same journal

Impact of Acute, Major Infrastructure Failure on Emergency Medical Service Transport Times in Rhode Island.

Rhode Island medical journal (2013)·2026
Same journal

Developing an Automated Text Message Program in the Emergency Department.

Rhode Island medical journal (2013)·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.0K

Current Applications of Intraperitoneal Chemotherapy.

Jenna Wilson1, Aishwarya Ayyappan1, Andrew B Crocker1

  • 1St. Elizabeth Medical Center, Brighton, MA.

Rhode Island Medical Journal (2013)
|June 25, 2025
PubMed
Summary
This summary is machine-generated.

Intraperitoneal chemotherapy (IPC) offers targeted treatment for peritoneal carcinomatosis by delivering drugs directly to the abdomen, enhancing efficacy and reducing systemic side effects. This review covers IPC agents, applications, and outcomes.

Keywords:
EPICHIPECIntraperitoneal Chemotherapyperitoneal carcinomatosis

More Related Videos

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.0K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.6K

Related Experiment Videos

Last Updated: Jul 2, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.0K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.0K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.6K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Pharmacology

Background:

  • Peritoneal carcinomatosis poses significant treatment challenges due to widespread, variable, and poorly vascularized metastases.
  • Intraperitoneal chemotherapy (IPC) was developed to overcome these challenges by local drug delivery.
  • IPC aims to increase drug concentration at tumor sites while minimizing systemic toxicity.

Purpose of the Study:

  • To review the molecular properties of intraperitoneal chemotherapy (IPC) agents.
  • To explore the clinical applications and outcomes of IPC in various cancers.
  • To highlight the potential of IPC as a life-saving treatment for peritoneal metastases.

Main Methods:

  • Review of existing literature on Intraperitoneal Chemotherapy (IPC).
  • Analysis of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Early Postoperative Intraperitoneal Chemotherapy (EPIC) protocols.
  • Examination of patient selection criteria and treatment effectiveness.

Main Results:

  • IPC enhances drug concentration in the peritoneal cavity.
  • HIPEC involves intraoperative hyperthermic administration; EPIC involves postoperative administration.
  • Effective patient selection is crucial for optimal outcomes, particularly after cytoreductive surgery.

Conclusions:

  • Intraperitoneal chemotherapy (IPC), including HIPEC and EPIC, presents a promising therapeutic strategy for peritoneal carcinomatosis.
  • Further research into IPC agents and outcomes can optimize treatment for patients with peritoneal metastases.
  • IPC has the potential to significantly improve survival and quality of life for affected patients.